Registered Members Login:
   
Forgotten Your Details? Click Here To Recover +
Welcome To The ShareCafe Community - Talk Shares And Take Stock With Smart Investors - New Here? Click To Register >

5075 Pages (Click to Jump) V  « < 954 955 956 957 958 959 960 > »    
 
  
Reply to this topic

CUV, CLINUVEL PHARMACEUTICALS LIMITED
LevelHeaded2000
post Posted: Sep 15 2018, 02:26 PM
  Quote Post


Posts: 557
Thanks: 1304


In Reply To: Verharven's post @ Sep 15 2018, 09:17 AM

Why do insurance companies do this? It seems like any USA insurance company would have the right to refuse a treatment not even approved in the USA. So, basically refusing these patients increase their bottom line. I know insurance companies have no soul, so why would they pay for this? Any insights?


Said 'Thanks' for this post: mrdax  johnnytech  
 
PunkassDerm
post Posted: Sep 15 2018, 02:17 PM
  Quote Post


Posts: 624
Thanks: 1679


In Reply To: investek's post @ Aug 19 2018, 09:14 PM

Followup on Investek post...

http://www.sachsforum.com/18bef-presenters.html


18TH ANNUAL BIOTECH IN EUROPE FORUM
4TH-5TH OCTOBER 2018 @ CONGRESS CENTER BASEL, SWITZERLAND

CLINUVEL AG

CLINUVEL PHARMACEUTICALS LTD is a global biopharmaceutical company focused on developing and delivering treatments for patients with a range of severe genetic and skin disorders. As pioneers in photomedicine and understanding the interaction of light and human biology, CLINUVEL’s research and development has led to innovative treatments for patient populations with a clinical need for photoprotection and regimentation. These patient groups range in size from 5,000 to 45 million worldwide.

CLINUVEL’s lead compound, SCENESSE® (afamelanotide 16mg), was approved by the European Commission in 2014 for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with the rare genetic disorder erythropoietic protoporphyria (EPP).

As the first ever photoprotective drug, SCENESSE® activates eumelanin, the dark pigment in skin. Eumelanin is capable of selective light absorption, including at the wavelengths of light which excite protoporphyrin IX, the compound which causes phototoxic reactions in patients diagnosed with EPP, a disorder which causes absolute intolerance to light (blue and green spectrum).
​
Headquartered in Melbourne, Australia, CLINUVEL has operations in Europe, Switzerland, the US and Singapore.

http://www.clinuvel.com/


Said 'Thanks' for this post: odi01  seeva222  
 
PunkassDerm
post Posted: Sep 15 2018, 01:43 PM
  Quote Post


Posts: 624
Thanks: 1679


In Reply To: Johnny H's post @ Sep 15 2018, 12:00 PM

Love to see that in email or letter, go public! FDA promotes a drug for US citizens, shouldn't it be FLASH tracked? Like instant approval!


Said 'Thanks' for this post: seeva222  johnnytech  
 
schlitzo
post Posted: Sep 15 2018, 01:42 PM
  Quote Post


Posts: 270
Thanks: 457


6 hot biotech stocks




http://www.thebull.com.au/premium/a/73920-...re-in-2018.html





Said 'Thanks' for this post: Dr Wally  San Diego  odi01  johnnytech  Texas T  
 
Johnny H
post Posted: Sep 15 2018, 12:00 PM
  Quote Post


Posts: 988
Thanks: 2084


In Reply To: Verharven's post @ Sep 15 2018, 11:04 AM

From Ms. Beck's page:

"Dr. Marcus of the FDA knows American citizens are going to Zurich. Her office recommended it as the best course of treatment to live with EPP."



--------------------
"In today’s world some shareholders enjoy complaining to Board and management but then they do not sell their stock, they hold on and sometimes buy even more."

Said 'Thanks' for this post: Verharven  San Diego  PunkassDerm  johnnytech  
 
Verharven
post Posted: Sep 15 2018, 11:04 AM
  Quote Post


Posts: 880
Thanks: 2327


In Reply To: San Diego's post @ Sep 15 2018, 10:35 AM

Hasn't answered it yet, but you can follow the comments on the page https://www.facebook.com/AccelerateApprovalOfAfamelanotide/


Said 'Thanks' for this post: San Diego  
 

Featured Stock Stories





seeva222
post Posted: Sep 15 2018, 10:36 AM
  Quote Post


Posts: 1,623
Thanks: 1857


In Reply To: Verharven's post @ Sep 15 2018, 09:17 AM

The flight to Switzerland is cheap compared to the cost

 
San Diego
post Posted: Sep 15 2018, 10:35 AM
  Quote Post


Posts: 165
Thanks: 346


In Reply To: Verharven's post @ Sep 15 2018, 09:17 AM

Did Gayle ever answer Patty's question? I would like to know the insurance company as well.

 
Verharven
post Posted: Sep 15 2018, 09:17 AM
  Quote Post


Posts: 880
Thanks: 2327


Some hard evidence of US insurers already covering the implant cost even when administered offshore

Attached thumbnail(s)
Attached Image


 



Said 'Thanks' for this post: Dr Wally  scipio79  seeva222  waz  San Diego  KRD  PunkassDerm  odi01  macgyver  Frogster  johnnytech  rabbitrun  Doogieson  
 
rabbitrun
post Posted: Sep 15 2018, 02:29 AM
  Quote Post


Posts: 924
Thanks: 1053


In Reply To: johnnytech's post @ Sep 15 2018, 01:29 AM

A rose by any other name. Whether it's an RTF or not, the FDA wants more info. We know what it is they're after, and it's not a big deal, so whatever you want to call it doesn't matter.

Still puzzling how this happened given the context of their submission process, but whatever. Just get the extra docs turned in and keep the wagons rolling.


Said 'Thanks' for this post: Desert Rat  mrdax  waz  Dr Wally  epimatic  
 
 


5075 Pages (Click to Jump) V  « < 954 955 956 957 958 959 960 > » 

Back To Top Of Page
Reply to this topic


You agree through the use of ShareCafe, that you understand and accept the TERMS OF USE.


TERMS OF USE  -  CONTACT ADMIN  -  ADVERTISING